Jiangsu Aidea Pharmaceutical Co., Ltd.

SHSE:688488 Stock Report

Market Cap: CN¥3.2b

Jiangsu Aidea Pharmaceutical Future Growth

Future criteria checks 2/6

Jiangsu Aidea Pharmaceutical is forecast to grow revenue at 36.9% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth34.3%
Revenue growth rate36.9%
Future return on equity0.3%
Analyst coverage

Low

Last updated07 Jun 2024

Recent future growth updates

No updates

Recent updates

Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) 30% Share Price Plunge Could Signal Some Risk

Jun 29
Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) 30% Share Price Plunge Could Signal Some Risk

Jiangsu Aidea Pharmaceutical (SHSE:688488) Is Making Moderate Use Of Debt

Jun 07
Jiangsu Aidea Pharmaceutical (SHSE:688488) Is Making Moderate Use Of Debt

Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) Shares Climb 27% But Its Business Is Yet to Catch Up

Mar 01
Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) Shares Climb 27% But Its Business Is Yet to Catch Up

Earnings and Revenue Growth Forecasts

SHSE:688488 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,080N/AN/A1092
12/31/2025835N/AN/A-1862
12/31/2024509N/AN/A12
3/31/2024392-90-255-180N/A
12/31/2023411-76-237-166N/A
9/30/2023412-80-203-115N/A
6/30/2023409-66-246-146N/A
3/31/2023322-101-233-123N/A
12/31/2022244-124-233-93N/A
9/30/2022180-114-204-69N/A
6/30/2022172-111-158-31N/A
3/31/2022213-64-169-41N/A
12/31/2021256-30-107-12N/A
9/30/202130917-129-40N/A
6/30/202131728-118-31N/A
3/31/202132248-944N/A
12/31/2020289401456N/A
9/30/2020327511641N/A
6/30/2020311427086N/A
3/31/2020309317090N/A
12/31/2019345342356N/A
12/31/20182779-123-33N/A
12/31/2017136-38N/A-67N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 688488's forecast earnings growth is above the savings rate (2.9%).

Earnings vs Market: Insufficient data to determine if 688488's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 688488's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688488's revenue (36.9% per year) is forecast to grow faster than the CN market (13.4% per year).

High Growth Revenue: 688488's revenue (36.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688488's Return on Equity is forecast to be low in 3 years time (0.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y